Canadian Corporate News - Biovail: Study Suggests Bedtime Dose Of Cardizem LA Protects Angina Patients From Morning Risks.
CHICAGO, ILLINOIS, Mar 30, 2003 (CCNMatthews via COMTEX)
Presentation at American College of Cardiology Shows New Formulation Doubles Morning Exercise Tolerance, a Key Angina Measure
Nighttime dosing of a newly approved blood pressure medication may provide angina patients with added protection in the morning hours when painful and potentially life-threatening attacks are most likely to occur, according to a study presented today at the 52nd Annual Scientific Session of the American College of Cardiology.
Most Popular
5 Regular Mistakes In Public Speaking
10 Jobs That Pay $30 An Hour
3 Questions No Job Seeker Ever Wants To Be Asked?
Public Speaking: 7 Secrets Of Great Public Speakers
13 Job Interview Mistakes To Avoid
Researchers reported that bedtime dosing of Cardizem(R) LA, a …
Read the rest of this article with a Free Trial at HighBeam Research.
